MORISHITA JINTAN CO.,LTD. Logo

MORISHITA JINTAN CO.,LTD.

Manufactures health products and provides OEM/ODM services using advanced encapsulation technology.

4524 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
大阪市中央区玉造一丁目2番40号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1893, Morishita Jintan Co., Ltd. is a multifaceted healthcare company engaged in the manufacture and sale of health-related products. The company's portfolio includes pharmaceuticals, quasi-drugs, medical devices, cosmetics, and health foods such as dietary supplements and probiotics. It is well-known for its 'Jintan' brand of oral care products. In addition to its direct-to-consumer offerings, Morishita Jintan provides Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services for the pharmaceutical and food industries, utilizing its expertise in advanced encapsulation technology to deliver high-quality, innovative healthcare solutions.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for MORISHITA JINTAN CO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-26 06:56
Regulatory News Service
臨時報告書
Japanese 23.4 KB
2025-06-20 08:44
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-20 08:41
Regulatory News Service
内部統制報告書-第88期(2024/04/01-2025/03/31)
Japanese 23.1 KB
2025-06-20 08:35
Annual Report
有価証券報告書-第88期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2024-11-12 07:15
Interim Report
半期報告書-第88期(2024/04/01-2025/03/31)
Japanese 179.7 KB
2024-11-12 07:13
Regulatory News Service
確認書
Japanese 8.1 KB
2024-06-27 04:45
Regulatory News Service
臨時報告書
Japanese 24.9 KB
2024-06-26 06:23
Regulatory News Service
確認書
Japanese 8.1 KB
2024-06-26 06:22
Regulatory News Service
内部統制報告書-第87期(2023/04/01-2024/03/31)
Japanese 22.2 KB
2024-06-26 06:21
Annual Report
有価証券報告書-第87期(2023/04/01-2024/03/31)
Japanese 1.0 MB
2024-02-08 05:32
Regulatory News Service
確認書
Japanese 8.1 KB
2024-02-08 05:31
Quarterly Report
四半期報告書-第87期第3四半期(2023/10/01-2023/12/31)
Japanese 162.1 KB
2023-11-09 05:31
Regulatory News Service
確認書
Japanese 8.1 KB
2023-11-09 05:30
Quarterly Report
四半期報告書-第87期第2四半期(2023/07/01-2023/09/30)
Japanese 177.7 KB
2023-08-09 04:47
Regulatory News Service
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all MORISHITA JINTAN CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for MORISHITA JINTAN CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Bioceltix S.A. Logo
Developing 'off-the-shelf' stem cell therapies for diseases in companion animals.
Poland BCX
Biofarm S.A. Logo
A top domestic manufacturer of pharmaceuticals, supplements, and soft gelatin capsules.
Romania BIO
Biofrontera AG Logo
Biopharma firm specializing in photodynamic therapy for dermatological conditions like actinic keratosis.
Germany B8F
BioGaia Logo
Develops and commercializes clinically proven probiotics for digestive health across all life stages.
Sweden BIOG
Bio-Gate AG Logo
Develops antimicrobial & antiviral tech for medical, cosmetic, & industrial products.
Germany BIG1
BioInfra Co.,Ltd. Logo
Offers cancer screening blood tests and provides CRO services to the pharmaceutical industry.
South Korea 199730
BioInfra Life Science Inc. Logo
Biotech specializing in oncology diagnostics and R&D for cancer gene treatments.
South Korea 266470
BioInvent International Logo
Develops first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden BINV
BioLineRx Ltd. Logo
Biopharma firm developing and commercializing therapies for cancer and rare diseases.
Israel BLRX
BioMaxima S.A. Logo
Manufacturer of IVD solutions including tests, reagents, and equipment for medical labs.
Poland BMX

Talk to a Data Expert

Have a question? We'll get back to you promptly.